SLC12A5 and epilepsy: These previous evidences and the results of the present work indicate that a mechanism of KD, as a non-pharmacological treatment for the control of the epilepsy, is probably by increasing KCC2 expression in the motor cortex (Wang et al., 2016), or in our case, in the dentate gyrus.